Scott J. Bergman, PharmD

Scott J. Bergman

Scott J. Bergman, PharmD, BCPS

Clinic Number:   217/545-8000
Department:    Department of Internal Medicine
Division:    Infectious Diseases
Administrative Title:    Adjunct Assistant Professor
Division of Infectious Diseases Department of Internal Medicine Southern Illinois University
School of Medicine
Springfield, IL

Associate Professor
Department of Pharmacy Practice
Southern Illinois University Edwardsville
School of Pharmacy
Edwardsville, IL

Faculty Rank:    Adjunct Associate Professor
Clinic Location:    751 N. Rutledge, Room 1100
Springfield, IL 62702
Pharmacy School:    South Dakota State University
Brookings, SD
Residency:    West Virginia University Hospitals and School of Pharmacy
Morgantown, WV
Licensure & Certification:   

West Virginia Board of Pharmacy
State of Illinois Registered Pharmacist
Board Certified Pharmacotherapy Specialist with Added Qualifications in Infectious Diseases


Current Research and Grants Beginning 2008

  1. Infectious Diseases Pharmacotherapy Residency – Principal Investigator (PI)
    Society of Infectious Diseases Pharmacists-Merck award: $40,000 funded 2012-13

  2. Sequential and combination antibiotic therapy for biofilm infections (PI)
    SIUE Graduate School Seed grant for Translational and Exploratory research Projects (STEP) award $16,000 funded 2011-12

  3. Oxacillin and rifampin combinations for Staphylococcus aureus biofilm infections (PI)
    SIUE School of Pharmacy research grant $2,500 funded 2011

  4. SIUE School of Pharmacy Seed grant for faculty development (PI)
    Laboratory research training program with Warren Rose, PharmD at the University of Wisconsin – Madison $5,000 funded 2010

  5. Vancomycin heteroresistance and susceptibility testing in Staphylococci (Co-I)
    PI was Vidya Sundareshan, MD, MPH at SIU School of Medicine Memorial Medical Foundation grant – Springfield, IL: $21,150 funded 2010-11

  6. Pharmacy-based influenza screening and treatment – Co-Investigator (Co-I)
    PI was Mike Klepser, PharmD, FCCP at Ferris State University – Kalamazoo, MI Gilead Sciences: $75,562.50 funded 2009-10

  7. Antibiotic activity against carbapenem-resistant Acinetobacter baumanii in biofilm (Co-I)
    PI was Cristian Speil, MD: SIU School of Medicine Seed Grant: $11,000 funded 2008-09


Articles Published Beginning 2008

  1. Huang V. Klepser ME. Gubbins PO. Bergman SJ, Chahine EB, Halilovic J, Hidayat L, Matthias DR, Tesh LD. Quantification of curricular content dedicated to point-of-care testing for infectious diseases in schools and colleges of pharmacy in the United States. Pharmacy Education (submitted)

  2. Shah PJ, Bergman SJ, Graham D, Glenn S. Monitoring of outpatient parenteral antimicrobial therapy (OPAT) and implementation of clinical pharmacy services at a community hospital infusion unit. Journal of Pharmacy Practice. Published ahead of print: Aug 2014

  3. Shah PJ. Bergman S, Vegi S, Sundareshan V. Fusarium peritonitis successfully managed with posaconazole and catheter removal. Peritoneal Dialysis International. 2014; 34:566-568

  4. Bergman SJ, Shah PJ. Chapter 139.  Dermatophytosis: Toeing the Line. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 9th ed. New York: McGraw-Hill; 2014.  p. 361-363

  5. Klepser ME, Hagerman JK, Klepser SA, Bergman SJ, Klepser DG. A community pharmacy-based influenza screening and management program shortens time to treatment versus pharmacy screening with referral to standard of care. Illinois Pharmacist. 2014; 76 (2): 12-18.

  6. Percival KM, Bergman SJ. Update on posaconazole pharmacokinetics: Comparison of new and old formulations. Current Fungal Infection Reports. 2014; 8: 139-145

  7. Santanello CD, Dow AC, Bergman SJ. Active Learning Strategies: Student Perceptions. Academic Exchange Quarterly. 2014; 18 (1):24-34

  8. Santanello CD, Bergman, SJ. Sarah’s Sickness: The Diagnosis and Treatment of an Infectious Disease. [Case Study] 2014. Buffalo, NY: National Center for Case Study Teaching in Science, University at Buffalo, State University of New York.

  9. Bergman SJ, Doss MM, Connor-Hustedde H. Fungal Infections. In: Mason B, Parker D, Lott RS, editors. Capstone Pharmacy Review. Burlington: Jones and Bartlett; 2014. p. 324-343.

  10. Campbell-Petkewicz KA, Bergman SJ, Otsuka ST, Collins-Lucey EH. Immunizations. In: Mason B, Parker D, Lott RS, eds. Capstone Pharmacy Review. Burlington: Jones and Bartlett; 2014. p. 712-720.

  11. Schmees PM, Bergman SJ, Strader BD, Metzke ME, Pointer S, Valenti KM,. Outcomes Of An Extended-Infusion Piperacillin-Tazobactam Protocol Implementation In A Community Teaching Hospital Adult Intensive Care Unit. Journal of Health-System Pharmacy Residents. 2013; 2 (2): 1-8.

  12. Shah PJ, Bergman S.  Skin and soft tissue infections.  A whole different ballgame in diabetics…or not? American Association of Diabetes Educators, Pharmacist community of interest blog. Jan 3rd, 2013

  13. Bergman SJ, Collins-Lucey EH. Update on Human Papillomavirus Vaccines: Life Saver or Controversy Magnet? Clinical Microbiology Newsletter. 2012; 34(11) 85-91

  14. Bergman SJ, Ferguson M, Santanello C. Interferons as therapeutic agents for infectious diseases.  Infectious Disease Clinics of North America. 2011; 25(4): 819-834.

  15. Bergman SJ. Dermatophytosis: Toeing the Line. In: Schwinghammer TL, Koehler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 8th ed. New York: McGraw-Hill; 2011 p. 353-5.

  16. Ahmed M, Bergman SJ, Khardori N.  Chapter 21. Antibiotics in Neurology Practice: Focus on Resource Limited Settings.  In: Misra UK, editor. Diagnosis and Management of Neurological Disorders. Gurgaon: Wolters Kluwer India; 2011 p. 341-356.

  17. Bergman SJ, Tyagi I, Ronald K. Antifungal dosing in critically ill patients. Current Fungal Infection Reports.2010; 4(2): 78-86

  18. Shahid M, Khardori N, Tripathi T, Bergman S. Pharmaco-EcoMicrobiology: A newer component to medical sciences bridging pharmacovigilance, ecology, and environmental microbiology.  J Infect and Public Health. 2010; 3: 1-4.

  19. Bergman SJ, Gonzalez M, Ronald K, Ruscin JM. Pharmacotherapy Update 2009, part II: Infectious disease, positive Beers criteria, and pharmacist intervention. Annals of Long-Term Care.2010; 18 (2) 41-44

  20. Bergman SJ.  Presumptive antimicrobial selection for emergencies in infectious disease.  In: Khardori NM and Wattal C, eds. Emergencies in Infectious Diseases: From Head to Toe.  1st ed. Delhi: Byword Books; 2010 p. 273-8

  21. Bergman SJ. Fun (and CE) in the Sun: A new practitioner’s view of the ASHP Midyear Clinical Meeting in Orlando, Florida. KeePosted – The official newsletter of the Illinois Council of Health-System Pharmacists.2009; 35: 13

  22. Bergman SJ, Slain D. Dermatophytosis: Toeing the Line. In: Schwinghammer TL, Koeler JM, eds. Pharmacotherapy Casebook: A Patient-Focused Approach. 7th ed. McGraw-Hill: New York, 2009 pp 315-6. 

  23. Htwe TH, Bergman S, Koirala J. Famcicovir substitution for patients with acyclovir-associated renal toxicity. Journal of Infection,2008; 57: 266-268

Comments? | Page last updated: December 3, 2014 | View our Privacy Policy
Please note that specific medical questions can not be answered via this website.